Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy

  • Quach, Hang; 
  • Nooka, Ajay; 
  • Samoylova, Olga; 
  • Venner, Christopher P.; 
  • Kim, Kihyun; 
  • 외 10명
Citations

WEB OF SCIENCE

11
Citations

SCOPUS

12

키워드

cancer; clinical studies; clinical trials; multiple myeloma; LENALIDOMIDE; BORTEZOMIB; SURVIVAL
제목
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
저자
Quach, Hang; Nooka, Ajay; Samoylova, Olga; Venner, Christopher P.; Kim, Kihyun; Facon, Thierry; Spencer, Andrew; Usmani, Saad Z.; Grosicki, Sebastian; Suzuki, Kenshi; Delimpasi, Sosana; Weisel, Katja; Obreja, Mihaela; Zahlten-Kumeli, Anita; Mateos, Maria-Victoria
DOI
10.1111/bjh.17541
발행일
2021-08
유형
Letter
저널명
British Journal of Haematology
권
194
호
4
페이지
784 ~ 788